Your browser doesn't support javascript.
Increasing patient participation in oncology clinical trials.
Chen, Jie; Lu, Ying; Kummar, Shivaani.
  • Chen J; Department of Biometrics, Overland Pharmaceuticals, Dover, Delaware, USA.
  • Lu Y; Department of Biomedical Data Science and Stanford Cancer Institute, Stanford University, Palo Alto, California, USA.
  • Kummar S; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA.
Cancer Med ; 2022 Aug 31.
Article in English | MEDLINE | ID: covidwho-2313589
ABSTRACT

AIM:

Timely recruitment of eligible participants is essential for the success of clinical trials, with insufficient accrual being the leading cause for premature termination of both oncology and non-oncology trials.

METHODS:

In this paper we further elaborate on the challenges for patient participation in oncology trials from physician, patient, healthcare system, and some trial-related perspectives.

RESULTS:

We present strategies such as use of digital healthcare technologies, real-world data and real-world evidence, decentralized clinical trials, pragmatic trial designs, and supportive services to increase patient participation.

CONCLUSIONS:

Multifaceted measures are necessary to increase patient participation, especially for those who are under-represented in cancer trials.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Randomized controlled trials Language: English Year: 2022 Document Type: Article Affiliation country: Cam4.5150

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Randomized controlled trials Language: English Year: 2022 Document Type: Article Affiliation country: Cam4.5150